VPSense

Quantum Doppler Sensor for Early Stroke Detection

Health Tech & Life Sciences
Active
Pre-Funding Caesarea, Israel Founded 2024
Website ↗ LinkedIn
Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2024
Headcount
6
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences

About

VPSense develops quantum-based medical sensing technology aimed at accelerating stroke diagnosis and intervention. Its platform analyzes Doppler signals to detect blood clots, offering rapid and actionable insights that support both immediate emergency care and long-term stroke management. The technology’s speed and precision aim to reduce the time between stroke onset and treatment, potentially lowering complication risks and improving outcomes.

Q&A

What is VPSense's primary focus?
VPSense develops quantum-based medical sensing technology to accelerate stroke diagnosis and intervention, utilizing Doppler signals to detect blood clots.
When was VPSense founded?
VPSense was founded in December 2024.
Where is VPSense headquartered?
VPSense is headquartered in Caesarea, Israel.
What is VPSense's current funding stage?
VPSense is currently in the Pre-Funding stage.
What sectors does VPSense operate in?
VPSense operates in Health Tech & Life Sciences, Medical Devices, and Medical Monitors sectors.
What is the main problem VPSense aims to solve?
VPSense aims to reduce the time between stroke onset and treatment, potentially lowering complication risks and improving outcomes through rapid and precise detection of blood clots.

Team · 1

Idan levy
Founder · CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Monitors
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

strokeearly-detectionwearablewearablemonitoringdigital-healthcare
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)